Work

Randomized multicenter phase Ib/II study of neoadjuvant chemoradiation therapy (CRT) alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic cancer.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.4128

Authors: Osama E. Rahma, Matthew H. G. Katz, Brian M. Wolpin, Andressa Dias-Costa, Jonathan Nowak, Scott J. Rodig, Stephanie Dougan, Tanios S. Bekaii-Saab, Chee-Chee H. Stucky, Rawad Elias, Gina R. Petroni, Todd W. Bauer, Craig L. Slingluff

Institutions: Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center, Brigham and Women's Hospital, Mayo Clinic, Mayo Clinic Hospital, Hartford Hospital, University of Virginia

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3170007902

Cites:

Cited by: 15

Related to: 10